image
Lyra Therapeutics, Inc. LYRA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.094
-2.49 %
$ 6.23 M
Market Cap
-0.08
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
190.33%
EBIT Estimate
9.23%
Net Income Estimate
20.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Lyra Therapeutics, Inc.
image
LYRA has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart LYRA

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart LYRA

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart LYRA

image
$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)202120212022202220232023202420242025202520262026202720272028202820292029